Literature DB >> 824686

A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.

S Moncada, R J Gryglewski, S Bunting, J R Vane.   

Abstract

Microsomal fractions from arterial walls of pigs and rabbits and fundus of rat stomach generate from prostaglandin endoperoxides (PGG2 or H2) an unstable substance, prostaglandin X (PGX) which is a potent inhibitor of platelet aggregation induced by several different substances. Other microsomal fractions including corpus of stomach, lung and ram seminal vesicles generate smaller amounts of PGX from PGG2 or PGH2. Incubation of microsomes from arterial wall or fundus of stomach with platelet-rich plasma under various conditions shows that the enzyme which generates PGX can utilize endoperoxides liberated from platelets or added to the cuvette, thereby preventing, interrupting or reversing the process of platelet aggregation. The generation of PGX is strongly inhibited (IC50 0.43 mug/ml) by 15-hydroperoxy arachidonic acid. These observations are important in the interpretation of vascular diseases such as atherosclerosis and thrombosis and provide a rational basis for the use of anti-oxidants in the prevention and treatment of these diseases.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824686     DOI: 10.1016/0090-6980(76)90048-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  64 in total

1.  Platelet aggregation in cerebral arterioles after percussive brain trauma.

Authors:  W I Rosenblum; E P Wei; H A Kontons
Journal:  Tex Heart Inst J       Date:  1982-09

Review 2.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

3.  Analysis of the uterine lumen in fertility-classified heifers: I. Glucose, prostaglandins, and lipids†.

Authors:  Joao G N Moraes; Susanta K Behura; Thomas W Geary; Thomas E Spencer
Journal:  Biol Reprod       Date:  2020-02-14       Impact factor: 4.285

4.  Healing of acetic acid-induced gastric ulcer and gastric mucosal PGI2 level in rats.

Authors:  M Uchida; O Kawano; N Misaki; K Saitoh; O Irino
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

5.  Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.

Authors:  P Needleman; A Raz; M S Minkes; J A Ferrendelli; H Sprecher
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

6.  Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.

Authors:  M Tissot; C Bonne; B Martin; M Solier; J P Giroud
Journal:  Agents Actions       Date:  1984-01

7.  Platelet and blood vessel arachidonate metabolism and interactions.

Authors:  P Needleman; A Wyche; A Raz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

8.  Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch.

Authors:  E A Higgs; G A Higgs; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

9.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors:  G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

10.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.